title: CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia.
abstract: Transepithelial migration of neutrophils (PMN) is a defining characteristic of active inflammatory states of mucosal surfaces. The process of PMN transepithelial migration, while dependent on the neutrophil beta 2 integrin CD11b/CD18, remains poorly understood. In these studies, we define a monoclonal antibody, C5/D5, raised against epithelial membrane preparations, which markedly inhibits PMN migration across polarized monolayers of the human intestinal epithelial cell line T84 in a bidirectional fashion. In T84 cells, the antigen defined by C5/D5 is upregulated by epithelial exposure to IFN-gamma, and represents a membrane glycoprotein of approximately 60 kD that is expressed on the basolateral membrane. While transepithelial migration of PMN was markedly inhibited by either C5/D5 IgG or C5/D5 Fab fragments, the antibody failed to inhibit both adhesion of PMN to T84 monolayers and adhesion of isolated T84 cells to the purified PMN integrin, CD11b/CD18. Thus, epithelial-PMN interactions blocked by C5/D5 appear to be downstream from initial CD11b/CD18-mediated adhesion of PMN to epithelial cells. Purification, microsequence analysis, and cross-blotting experiments indicate that the C5/D5 antigen represents CD47, a previously cloned integral membrane glycoprotein with homology to the immunoglobulin superfamily. Expression of the CD47 epitope was confirmed on PMN and was also localized to the basolateral membrane of normal human colonic epithelial cells. While C5/D5 IgG inhibited PMN migration even in the absence of epithelial, preincubation of T84 monolayers with C5/D5 IgG followed by antibody washout also resulted in inhibition of transmigration. These results suggest the presence of both neutrophil and epithelial components to CD47-mediated transepithelial migration. Thus, CD47 represents a potential new therapeutic target for downregulating active inflammatory disease of mucosal surfaces.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Parkos
authors.forename: S P
authors.initials: SP
authors.lastname: Colgan
authors.forename: T W
authors.initials: TW
authors.lastname: Liang
authors.forename: A
authors.initials: A
authors.lastname: Nusrat
authors.forename: A E
authors.initials: AE
authors.lastname: Bacarra
authors.forename: D K
authors.initials: DK
authors.lastname: Carnes
authors.forename: J L
authors.initials: JL
authors.lastname: Madara
mesh_terms: D000595:Amino Acid Sequence; D000704:Analysis of Variance; D015703:Antigens, CD / Q000737:chemistry / Q000302:isolation & purification / Q000502:physiology*; D018845:CD11 Antigens / Q000502:physiology; D018821:CD18 Antigens / Q000502:physiology; D051928:CD47 Antigen; D002352:Carrier Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000502:physiology*; D002448:Cell Adhesion; D002460:Cell Line; D002462:Cell Membrane / Q000502:physiology / Q000648:ultrastructure; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte; D003106:Colon / Q000276:immunology / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D004848:Epithelium / Q000502:physiology; D005434:Flow Cytometry; D006801:Humans; D007074:Immunoglobulin G; D007371:Interferon-gamma / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000276:immunology / Q000502:physiology*; D007422:Intestines; D008961:Models, Structural; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000502:physiology*; D017433:Protein Structure, Secondary
chemical_list: D015703:Antigens, CD; D018845:CD11 Antigens; D018821:CD18 Antigens; D051928:CD47 Antigen; C497894:CD47 protein, human; D002352:Carrier Proteins; D007074:Immunoglobulin G; D007371:Interferon-gamma